—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Axsome Therapeutics Inc (AXSM) — Technical state

As of 2026-11-02 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 36 out of 100 (momentum 12 · quality 23 · valuation 19), as of 2026-11-03.
  • Signal: Downtrend stack — Trades -25.8% vs the 50-day and -31.7% vs the 200-day average, 47.7% below the 52-week high and +10.6% off the 52-week low; a death cross printed 14 sessions ago. Computed from daily closes. (as of 2026-11-02)
  • Trend: Axsome Therapeutics Inc trades 25.8% below its 50-day and 31.7% below its 200-day moving average. (as of 2026-11-02)

Axsome Therapeutics is a biopharmaceutical company that develops treatments for central nervous system disorders, based in New York. Its marketed products are Auvelity for major depressive disorder, Sunosi for excessive daytime sleepiness in narcolepsy or sleep apnoea, and Symbravo for acute migraine.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the AXSM overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Downtrend stack

Trades -25.8% vs the 50-day and -31.7% vs the 200-day average, 47.7% below the 52-week high and +10.6% off the 52-week low; a death cross printed 14 sessions ago. Computed from daily closes.

Ranked #49 on today’s Directional Flow — Falling fastest list (scan of 2026-11-02).

The moving-average stack

Continue: the AXSM chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-02

Quick answers

What is the current Closelooknet signal on AXSM?

Downtrend stack — Trades -25.8% vs the 50-day and -31.7% vs the 200-day average, 47.7% below the 52-week high and +10.6% off the 52-week low; a death cross printed 14 sessions ago. Computed from daily closes. As of 2026-11-02; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is AXSM above its 50-day and 200-day moving averages?

As of 2026-11-02, Axsome Therapeutics Inc trades -25.8% below its 50-day and -31.7% below its 200-day average, with the 20-day -12.7% away.

How far is AXSM from its 52-week high?

47.7% below the 52-week high and 10.6% above the 52-week low, as of 2026-11-02.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.